Viewing by:
X-Therma CEO Dr. Xiaoxi Wei’s career development story is featured in Chemical &Engineering News (C&EN, Volume 95 Issue 23 | p. 23| Issue Date: June
X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract. This contract funds genitourinary organ transplants performed with XT-ViVoTM cryopreserved
X-Therma is featured in “Wirtschaftswoche“ – top weekly magazine in German Economy. —59 Valley Talk: Investoren begeistern sich für Transplantationstechnik, WirtschaftsWoche Ausgabe 42/2016
Future talk at 2b AHEAD Congress 2016 in Germany – Our CEO Xiaoxi Wei shared our future vision on saving lives and building a greener Earth by advancing anti-Ice
X-Therma is competitively selected by for a US Department of Defense Phase II SBIR contract. Murine heart transplants will be performed with XT-ViVoTM cryo
Congratulations to X-Therma Inc. for the Patrick Soon-Shiong Innovation Award 2015 hosted by the Los Angeles Business Journal!
Fun debut at the Atomic precision for medical application workshop hosted by Foresight institute.
X-Therma is granted by U.S. Department of Defense for Phase I research on developing breakthrough cryoprotective agents (CPAs) for large organ/tissue cryopreservation!
625 Alfred Nobel Drive
Suite B
Hercules, CA 94547
USA
X-Therma GmbH
Langer Weg 11
6020 Innsbruck
Austria
